Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Archives of Toxicology|July 11, 2002
Low doses of 2,3,7,8-tetrachlorodibenzo- p-dioxin increase transforming growth factor beta and cause myocardial fibrosis in marmosets ( Callithrix jacchus)Kai Riecke, Daniela Grimm, Mehdi Shakibaei, et al.
The Lancet. Infectious Diseases|March 16, 2005
Treatment and vaccines for severe acute respiratory syndromeDavid A Groneberg, Susan M Poutanen, Donald E Low, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 1, 1997
Pharmacokinetics of cefetamet pivoxil and interaction with cisapride and N-acetylcysteineKlaus-Jürgen Gutleben, Jörg Eller, Jessica Vöckler, et al.
Scandinavian Journal of Infectious Diseases|February 18, 2003
Single- and multiple-dose pharmacokinetics of oral moxifloxacin and clarithromycin, and concentrations in serum, saliva and faecesOlaf Burkhardt, Klaus Borner, Heino Stass, et al.
Chest|April 14, 2004
Viral community-acquired pneumonia in nonimmunocompromised adultsAndrés de Roux, Maria A Marcos, Elisa Garcia, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2004
Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized studyMathias W R Pletz, Andres De Roux, Andreas Roth, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 22, 2002
Changes in fecal flora and comparative multiple-dose pharmacokinetics of ceftibuten, cefpodoxime proxetil and amoxycillin/clavulanateJürg Hamacher, Jörg Luepke, Bruce E. Reidenberg, et al.
The Journal of Antimicrobial Chemotherapy|October 31, 2002
Single- and multiple-dose pharmacokinetics of linezolid and co-amoxiclav in healthy human volunteersOlaf Burkhardt, Klaus Borner, Nicolas von der Höh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 25, 2002
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosisDavid W Denning, Patricia Ribaud, Noel Milpied, et al.
GMS Infectious Diseases|May 7, 2020
Calculated parenteral initial treatment of bacterial infections: Respiratory infectionsSebastian R Ott, Klaus-Friedrich Bodmann, Béatrice Grabein, et al.
Pageof 11